Clinical Trial Update: Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial [Phase 4]

View source ↗

Summary

Phase 4 pediatric trial comparing two separate injections of insulin detemir and insulin aspart twice daily to a twice-daily extemporaneous insulin mix regimen,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)
• NovoLog (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED | Results posted: 2013-01-18